Didier Jutras-Aswad
Datos Biográficos
| ID | 326720 |
|---|---|
| NOMBRE | Didier Jutras-Aswad |
| NOMBRES | Didier |
| APELLIDO | Jutras-Aswad |
| FIRMA | JUTRAS-ASWAD D |
| AFILIACIONES | Centre Hospitalier de l’Université de Montréal |
| ORCID | 0000-0002-8474-508X |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 38 |
| TOTAL DE CITAS | 1 |
| TOTAL COMO AUTOR | 38 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2012 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 1 |
Substance use amongst individuals with internet gaming disorder and gaming disorder
‘Involuntary treatment’ for severe substance use disorders (SUDs). An overview of key issues, experiences and outcomes for consideration in policy development in Canada
Background In the midst an ongoing public health-crisis from toxic drug use, overdose deaths and compromised community safety, policy-officials in Canada have called to consider mobilizing ‘involuntary treatment’ (InvTx) measures for severe substance use disorders (SUDs) as interventions to reduce related health and social burdens.Methods We identified conceptual, socio-legal/-historical, clinical/epidemiological and other empirical literature- a…
Differential Impacts of Methadone and Buprenorphine/Naloxone on Pain‐Related Outcomes Among People With Non‐Heroin Opioid Use Disorder
Uncovered, underfunded, and undervalued
BACKGROUND: Pragmatic trials evaluate the effectiveness or feasibility of a treatment in clinical practice. However, in substance use research, the "real world" is characterized by patterns of structural stigma embedded in everchanging drug policies and public perceptions that vary by jurisdiction. While such contextual influences typically go unmeasured in clinical research, these localized features may shape participants' trial experiences and …
Cannabis consumption and problematic internet use
Cannabis, the most consumed illicit drug globally, has been legal for non-medical use in Canada since 2018. Problematic internet use is considered a behavioral addiction involving excessive online activities (e.g., social media, video watching), which can cause social isolation, family issues, psychological distress, and even suicide ideation. Studies mainly conducted with adolescents indicate a link between cannabis use disorder and problematic …
Outcomes and implications of British Columbia’s ‘drug decriminalization initiative’ for health-oriented drug policymaking
Las ‘Guías para el Uso de Cannabis de Menor Riesgo (GUCMR)’
A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda
Safe(r) supply encompasses prescribed opioid alternatives interventions (safer supply) and non-medicalized (safe supply) approaches with shared antecedents but distinct attributes and consequences. This study highlights the need to better define and standardize the parameters of safer supply approaches, including population, dosing, and intended objectives, to enable a more precise assessment of their potential benefits and risks. This nuanced un…
Die ‘Richtlinien für die Risiko-Reduzierung beim Cannabiskonsum (RRRCK)’
Les ‘Lignes Directrices Pour l'Usage du Cannabis à Moindre Risque (LUCMR)’
Exploring the role of primary regulation differences for cannabis legalization outcomes – preliminary data from two Canadian provinces
Background: Cannabis legalization policy is increasingly implemented to improve public health and safety outcomes, including in Canada (since 2018). Main outcome assessments have primarily focused on categorical (e.g. pre-/post-) legalization policy reform effects, while differential regulation frameworks have been less considered. For this, Canada provides a rich ecology where provinces diversely define many regulation parameters under the feder…
Measurement of Impulsivity and Its Role in Drug Use Behaviours and Related Health, Harm and Treatment Outcomes Among People Who Use Illicit Drugs—A Scoping Review
Impulsivity is closely implicated in substance use disorders; however, its definition and assessment among people who use illicit drugs (PWUD) are lacking consistency. This scoping review maps the existing evidence on how impulsivity has been defined, measured, and linked to drug use behaviours and consequences. A systematic search of manuscripts (1990–2025) was conducted across multiple databases, identifying 267 eligible studies. Behavioural ta…
Trying to get down here when the dealer's closer
Three noteworthy idiosyncrasies related to Canada's opioid‐death crisis, and implications for public health‐oriented interventions
Canada has been experiencing a prolonged public health‐crisis of high rates of overdose deaths caused by exceptionally potent/toxic, illicit opioid use. While many key features of this drug death epidemic are well‐documented, several idiosyncratic aspects with relevance for public health‐oriented interventions are not adequately recognised. These include: (i) the discrepant opioid patterns pan‐Canada, with large majorities of opioid deaths caused…
Characterising methamphetamine/amphetamine use among opioid agonist therapy‐seeking adults with prescription‐type opioid use disorder in Canada
Determinants of psychological distress during the Covid ‐19 pandemic among people who use drugs in Montreal, Canada
People with opioid use disorders
Binge Drug Injection in a Cohort of People Who Inject Drugs in Montreal
The online version contains supplementary material available at 10.1007/s11469-023-01207-7
Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada
Purpose Using data from a randomized controlled trial for treatment of prescription-type opioid use disorder in Canada, this study examines sensitivity to change in three preference-based instruments [EQ-5D-3L, EQ-5D-5L, and the Health Utilities Index Mark 3 (HUI3)] and explores an oft-overlooked consideration when working with contemporaneous responses for similar questions—data quality. Methods Analyses focused on the relative abilities of thre…
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use
BACKGROUND: Cannabis use is common, especially among young people, and is associated with risks for various health harms. Some jurisdictions have recently moved to legalization/regulation pursuing public health goals. Evidence-based 'Lower Risk Cannabis Use Guidelines' (LRCUG) and recommendations were previously developed to reduce modifiable risk factors of cannabis-related adverse health outcomes; related evidence has evolved substantially sinc…
Harm reduction interventions as a potential solution to managing cannabis use in people with psychosis
Research Participation in Substance Use Disorder Trials
Background Given the health and social harms of problematic substance use, randomized controlled trials (RCTs) are critical in developing and testing pharmacotherapies for substance use disorders. However, substance use RCTs can be challenging to conduct, considering the social and structural barriers to participating in research among people with substance use disorders (PSUD), including stigma, poverty, and criminalization-factors that can shap…
Using administrative health data to estimate prevalence and mortality rates of alcohol and other substance‐related disorders for surveillance purposes
Premier épisode psychotique et trouble de l’usage de substance concomitants
Objectifs Environ la moitié des jeunes adultes atteints de psychose débutante présentent aussi des troubles de l’usage de substance (TUS). Les impacts de la persistance des TUS sont importants et affectent négativement le pronostic symptomatique et fonctionnel, de même que la prise en charge des jeunes après un premier épisode psychotique (PEP). Cet article vise à identifier et à synthétiser les approches thérapeutiques les mieux démontrées comme…
Injecting frequency trajectories and hepatitis C virus acquisition
Traitement intégré de l’hépatite C auprès des personnes avec des troubles concomitants de santé mentale et de dépendance
Dans cet article, les auteurs examinent l’ampleur de la problématique de l’infection par le virus de l’hépatite C (VHC) en milieu urbain et les obstacles à l’obtention des soins pour les personnes atteintes de comorbidité psychiatrique et toxicomanie. Ils rappellent que l’infection par le VHC est associée à une détérioration de la qualité de vie et à un risque élevé de cirrhose, mais que les traitements de plus en plus efficaces développés au cou…
Traitement intégré de la comorbidité toxicomanie et santé mentale chez les populations urbaines
La prévalence des patients qui présentent une problématique psychiatrique et de toxicomanie (dits troubles concomitants) est élevée. Montréal, comme d’autres grands centres urbains, est un lieu d’accueil pour un nombre élevé d’entre eux. Malgré la disponibilité des ressources pour traiter chacune de ces affections, il y avait jusqu’à récemment un manque de programmes qui offraient des modalités de traitement intégré. Au cours des dernières années…
Le craving comme symptôme central de la toxicomanie
Le craving, ce désir intense de consommer , est un symptôme central de la toxicomanie. Jusqu’au début des années 2000, peu d’outils existaient afin d’étudier le phénomène de manière plus concrète pour mieux le définir, le comprendre et approfondir les fondements neurobiologiques qui le sous-tendent. Avec les avancées technologiques des dernières années (IRM fonctionnelle, PET Scan), puis l’arrivée du DSM-V et son inclusion comme critère diagnosti…
Exploration des mécanismes potentiels sous-jacents aux troubles liés à l’utilisation d’une substance chez les personnes atteintes d’un trouble de la personnalité
Introduction Les troubles de la personnalité appartenant au groupe B du DSM-V, notamment les troubles de la personnalité limite et antisociale, sont associés à des taux élevés de problèmes liés à l’utilisation d’une substance. Les mécanismes qui pourraient expliquer cette relation demeurent cependant mal compris. Le craving a par ailleurs récemment été reconnu comme étant une composante majeure des troubles liés à l’utilisation d’une substance. L…
Présentation
Présentation : nouveaux paradigmes en toxicomanie : complexité et phénomènes émergents à l’avant-plan. Un article de la revue Santé mentale au Québec (Nouveaux paradigmes en toxicomanie : complexité et phénomènes émergents à l’avant-plan) diffusée par la plateforme Érudit
Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting
I love having benzos after my coke shot”
Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection
Le marché légal du cannabis suite à sa légalisation au Canada
Transitioning from interferon-based to direct antiviral treatment options
The Impact of Treatment Orders for Residential Treatment of Comorbid Severe Substance Use Disorders for Youth Suffering from Early Psychosis
Using administrative health data to estimate prevalence and mortality rates of alcohol and other substance‐related disorders for surveillance purposes
Premier épisode psychotique et trouble de l’usage de substance concomitants
Objectifs Environ la moitié des jeunes adultes atteints de psychose débutante présentent aussi des troubles de l’usage de substance (TUS). Les impacts de la persistance des TUS sont importants et affectent négativement le pronostic symptomatique et fonctionnel, de même que la prise en charge des jeunes après un premier épisode psychotique (PEP). Cet article vise à identifier et à synthétiser les approches thérapeutiques les mieux démontrées comme…
Injecting frequency trajectories and hepatitis C virus acquisition
Socioeconomic stability is associated with lower injection frequency among people with distinct trajectories of injection drug use
Gender-specific associations between psychological distress and injecting risk behaviours among people who inject drugs in Montreal, Canada
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use
BACKGROUND: Cannabis use is common, especially among young people, and is associated with risks for various health harms. Some jurisdictions have recently moved to legalization/regulation pursuing public health goals. Evidence-based 'Lower Risk Cannabis Use Guidelines' (LRCUG) and recommendations were previously developed to reduce modifiable risk factors of cannabis-related adverse health outcomes; related evidence has evolved substantially sinc…
Harm reduction interventions as a potential solution to managing cannabis use in people with psychosis
Research Participation in Substance Use Disorder Trials
Background Given the health and social harms of problematic substance use, randomized controlled trials (RCTs) are critical in developing and testing pharmacotherapies for substance use disorders. However, substance use RCTs can be challenging to conduct, considering the social and structural barriers to participating in research among people with substance use disorders (PSUD), including stigma, poverty, and criminalization-factors that can shap…
People with opioid use disorders
Binge Drug Injection in a Cohort of People Who Inject Drugs in Montreal
The online version contains supplementary material available at 10.1007/s11469-023-01207-7
Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada
Purpose Using data from a randomized controlled trial for treatment of prescription-type opioid use disorder in Canada, this study examines sensitivity to change in three preference-based instruments [EQ-5D-3L, EQ-5D-5L, and the Health Utilities Index Mark 3 (HUI3)] and explores an oft-overlooked consideration when working with contemporaneous responses for similar questions—data quality. Methods Analyses focused on the relative abilities of thre…
Three noteworthy idiosyncrasies related to Canada's opioid‐death crisis, and implications for public health‐oriented interventions
Canada has been experiencing a prolonged public health‐crisis of high rates of overdose deaths caused by exceptionally potent/toxic, illicit opioid use. While many key features of this drug death epidemic are well‐documented, several idiosyncratic aspects with relevance for public health‐oriented interventions are not adequately recognised. These include: (i) the discrepant opioid patterns pan‐Canada, with large majorities of opioid deaths caused…
Characterising methamphetamine/amphetamine use among opioid agonist therapy‐seeking adults with prescription‐type opioid use disorder in Canada
Determinants of psychological distress during the Covid ‐19 pandemic among people who use drugs in Montreal, Canada
Medicine (26 obras) · Psychiatry (19 obras) · Substance Abuse Treatment and Outcomes (19 obras) · HIV, Drug Use, Sexual Risk (14 obras) · Internal Medicine (11 obras) · Opioid Use Disorder Treatment (11 obras) · Cannabis (9 obras) · Demography (9 obras) · Environmental health (8 obras) · Psychology (8 obras)